- Report
- May 2025
- 196 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- April 2025
- 150 Pages
Global
From €2635EUR$2,999USD£2,273GBP
- Report
- March 2025
- 185 Pages
Global
From €3361EUR$3,825USD£2,899GBP
€3954EUR$4,500USD£3,411GBP
- Report
- August 2024
- 164 Pages
Global
From €4389EUR$4,995USD£3,786GBP
- Report
- May 2024
- 139 Pages
Global
From €5710EUR$6,499USD£4,926GBP
- Report
- October 2022
- 119 Pages
Global
From €3954EUR$4,500USD£3,411GBP
- Report
- February 2023
- 198 Pages
Global
From €6590EUR$7,500USD£5,685GBP
- Report
- September 2022
- 149 Pages
Global
From €3163EUR$3,600USD£2,729GBP
Ramelteon is a prescription medication used to treat insomnia. It is classified as a central nervous system (CNS) drug, which are drugs that act on the brain and spinal cord to produce their effects. Ramelteon works by binding to melatonin receptors in the brain, which helps to regulate the body's sleep-wake cycle. It is typically used for short-term treatment of insomnia, and is not recommended for long-term use.
Ramelteon is available in tablet form and is taken orally. It is typically taken once a day, 30 minutes before bedtime. Common side effects include headache, dizziness, and nausea.
The Ramelteon market is highly competitive, with several major pharmaceutical companies offering the drug. These include Takeda Pharmaceuticals, Sunovion Pharmaceuticals, and Eisai Co. Ltd. Show Less Read more